Lexeo TherapeuticsLXEO

那斯達克 · USD
4.54
-0.23
(-4.73%)
盤中 09/10 03:44 (UTC+8)
09/10 03:44 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
營業收入淨額
-
-
-
-
-
-
-
-
-
-
營業成本
----------
營業毛利
-
-
-
-
-
-
-
-
-
-
營業費用
28,02022,33323,11621,64830,68833,80527,38231,54323,55023,291
研發費用
19,02715,70316,21015,69514,72117,17118,36623,42316,56015,742
推銷及管理費用
8,9936,6306,9065,95315,96716,6349,0168,1206,9907,549
非經常性項目費用
----------
其他營業費用
----------
營業利益
-28,020
-22,333
-23,116
-21,648
-30,688
-33,805
-27,382
-31,543
-23,550
-23,291
其他收入及費用
2,1672,1542,2171,3874,6101,1771,4882,0892,3471,646
利息費用
14172022252830353537
稅前純益
-25,867
-20,196
-20,919
-20,283
-26,103
-32,656
-25,924
-29,489
-21,238
-21,682
所得稅
----------
稅後純益
-25,867
-20,196
-20,919
-20,283
-26,103
-32,656
-25,924
-29,489
-21,238
-21,682
基本每股稅後盈餘(元)
-0.30-0.25-0.27-0.33-0.60-0.99-0.79-0.89-0.64-0.77
稀釋每股稅後盈餘(元)
-0.30-0.25-0.14-0.19-0.54-0.99-0.78-0.90-0.64-0.77
基本平均股數(千股)
85626.0081183.0076356.0060980.0043573.0033113.0033106.0033063.0033001.0027979.00
稀釋平均股數(千股)
85626.0081183.0076356.0060980.0043573.0033113.0033106.0033063.0033001.0027979.00
還原基本每股稅後盈餘(元)
-0.30-0.25-0.27-0.33-0.60-0.99-0.79-0.89-0.64-0.77
還原稀釋每股稅後盈餘(元)
-0.30-0.25-0.14-0.19-0.54-0.99-0.78-0.90-0.64-0.77
還原基本平均股數(千股)
85,62681,18376,35660,98043,57333,11333,10633,06333,00127,979
還原稀釋平均股數(千股)
85,62681,18376,35660,98043,57333,11333,10633,06333,00127,979
EBITDA(千元)
-25,758-20,148-20,821-20,128-25,982-32,556-25,842-29,371-21,126-21,576

大家都在看

HOT